TGFB1 single-nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. In regard to Peters et al. (Int J Radiat Oncol Biol Phys 2008;70:752-759)
Department of Therapeutic Radiology and Oncology, Medical University of Graz, Graz, Austria; Department of Internal Medicine, General Hospital Fürstenfeld, Fürstenfeld, Austria